Prospective Validation of AKI Prediction
Part of paid clinical trials in Rochester, New York.
- Sponsor
- Adam C Dziorny
- Study ID
- NCT06804200
- Status
- Recruiting
Conditions
- Acute Kidney Injury
Eligibility Criteria
- Sex
- ALL
- Age
- 30 Days - 18 Years
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this prospective observational study is to implement, deploy, and quantify accuracy of an existing Pediatric Early AKI Risk Score algorithm. The implementation will be facilitated using a Health Level 7 (HL7) Fast Healthcare Interoperability Resource (FHIR)-based architecture. Investigators will deploy this model and store results in a manner not viewable to the clinical team caring for the patient. To determine the accuracy of the implemented prediction model, Investigators will prospectively identify patients with AKI at 72 hours following ICU admission. Investigators hypothesize that this model will prospectively detect AKI with a sensitivity \>70% and a positive predictive value \>20%, both chosen a priori as 10% improvement over the initial Pediatric AKI Risk Score tool.
Key Dates
- Start date
- Jun 25, 2025
- Status verified
- Apr 2026
- Primary completion
- Jun 1, 2026
- Completion
- Jun 1, 2026
Study Design
- Enrollment
- 800 participants (estimated)
Arms
- Arm: Pediatric ICU AdmissionsThe study subjects are all patients admitted to the pediatric intensive care unit and the pediatric cardiac care unit at Golisano Children's Hospital at Strong. By virtue of admission to a pediatric hospital bed, all subjects will be children. The rationale for focusing on this population is that the developed algorithm focuses on identifying acute kidney injury among critically ill pediatric patients. The gender and age of subjects will not influence enrollment. To accurately determine algorithm test characteristics (sensitivity, PPV, NNA) pragmatically, Investigators must include all admitted patients. Missing patients may bias our results and invalidate the study.
Primary Outcome Measure
Acute Kidney Injury (AKI) within the first 72 hours of ICU admission [ Time Frame: Within 72 hours following ICU Admission ]
Central Contacts
- Adam C Dziorny, MD, PhD585-276-3014
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Golisano Children's Hospital at Strong | Rochester | New York | 14642 | - |
Find similar trials in Rochester, NY
Related Studies
- CTSN Embolic Protection TrialRecruiting · Icahn School of Medicine at Mount Sinai · North Little Rock, Arkansas
- Nafamostat Efficacy in Phase 3 Registrational CRRT StudyRecruiting · Talphera, Inc · Los Angeles, California
- Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0Enrolling By Invitation · Indiana University · Birmingham, Alabama
- Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney InjuryPHASE2 · Recruiting · Giuseppe Cullaro, MD · New York, New York